EIS - ETF AI Analysis
Top Page
iShares MSCI Israel ETF (EIS)
Rating:59Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and in recent months, showing positive momentum.
Leading Israeli Companies in Top Holdings
Several major positions, including banks, technology, and defense firms, have shown strong year-to-date performance, helping support the fund’s returns.
Broad Sector Diversification
Holdings spread across financials, technology, real estate, health care, industrials, and other sectors help reduce the impact of weakness in any single industry.
Negative Factors
High Country Concentration
Most of the portfolio is invested in Israel, so the fund is heavily exposed to the economic and geopolitical risks of a single country.
Financial Sector Dominance
A large share of assets is in financial stocks, which can make the ETF more sensitive to banking and interest-rate related shocks.
Relatively High Expense Ratio
The fund’s ongoing fee is on the higher side for an ETF, which can modestly reduce investors’ net returns over time.
EIS vs. SPDR S&P 500 ETF (SPY)
AUM879.49M
RegionMiddle East & Africa
Expense Ratio0.59%
Beta0.83
IssueriShares
Inception DateMar 26, 2008
Dividend Yield1.56%
Asset ClassEquity
Index TrackedMSCI Israel Capped Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume81,377
30 Day Avg. Volume97,773
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EIS Summary
The iShares MSCI Israel ETF (EIS) is a fund that follows the MSCI Israel Capped Index, giving you broad exposure to the Israeli stock market in a single investment. It holds a mix of banks, technology, healthcare, and other companies, including well-known names like Teva Pharmaceutical and Check Point Software. Someone might invest in EIS to diversify internationally and tap into Israel’s technology-driven growth while still owning a range of sectors. A key risk is that it is concentrated in one country, so its price can rise or fall sharply with Israel’s economy and regional tensions.
How much will it cost me?The iShares MSCI Israel ETF (EIS) has an expense ratio of 0.59%, meaning you’ll pay $5.90 per year for every $1,000 invested. This is higher than average for ETFs because it is passively managed but focuses on a niche market, which can involve higher costs to track the index effectively.
What would affect this ETF?The iShares MSCI Israel ETF (EIS) could benefit from Israel's strong presence in technology and healthcare, sectors known for innovation and growth potential. However, challenges such as geopolitical tensions in the Middle East or changes in global interest rates affecting financial institutions could negatively impact the ETF's performance. Investors should also consider how broader economic conditions and regulatory changes in Israel might influence its top holdings, including major banks and tech companies.
EIS Top 10 Holdings
This Israel-focused ETF leans heavily on a mix of banks and tech, with all its firepower concentrated in the local market. Tower and Nova have been the standouts, riding the global semiconductor wave and giving the fund a solid lift, while Enlight Renewable Energy adds a greener growth angle with a rising share price. On the flip side, big banks like Leumi, Poalim, Discount, and Mizrahi Tefahot have been lagging, acting like a weight on the fund. Teva and Elbit are more mixed, keeping overall performance on a somewhat bumpy but balanced path.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Teva Pharmaceutical | 9.86% | $89.56M | $40.72B | 109.44% | 63 Neutral | |
| Leumi | 8.10% | $73.52M | ₪100.36B | 14.81% | 80 Outperform | |
| Poalim | 7.22% | $65.54M | ₪91.41B | 14.37% | 79 Outperform | |
| Tower | 6.03% | $54.79M | ₪74.31B | 385.26% | ― | |
| Elbit Systems | 5.50% | $49.96M | ₪114.90B | 60.79% | 73 Outperform | |
| Nova | 3.55% | $32.26M | ₪45.04B | 58.11% | ― | |
| Phoenix | 3.17% | $28.79M | ₪43.69B | 76.56% | 79 Outperform | |
| Discount | 3.01% | $27.32M | ₪37.48B | -4.14% | 75 Outperform | |
| Enlight Renewable Energy | 2.95% | $26.76M | $11.89B | 198.98% | 77 Outperform | |
| Check Point | 2.60% | $23.65M | $14.24B | -38.66% | 76 Outperform |
EIS Technical Analysis
Negative
―
Price Trends
127.76
Negative
124.59
Negative
115.53
Positive
Market Momentum
-2.16
Negative
41.61
Neutral
57.98
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EIS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 121.85, equal to the 50-day MA of 127.76, and equal to the 200-day MA of 115.53, indicating a neutral trend. The MACD of -2.16 indicates Negative momentum. The RSI at 41.61 is Neutral, neither overbought nor oversold. The STOCH value of 57.98 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EIS.
EIS Peer Comparison
Comparison Results
Performance Comparison
EIS
iShares MSCI Israel ETF
119.51
24.21
25.40%
JHMD
John Hancock Multifactor Developed International ETF
―
―
―
SYLD
Cambria Shareholder Yield ETF
―
―
―
FDMO
Fidelity Momentum Factor ETF
―
―
―
EWS
iShares MSCI Singapore ETF
―
―
―
ISRA
VanEck Israel ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents